A Clinical Evaluation of NobelProcera Implant Bar Overdenture
Primary Purpose
Edentulous
Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
NobelReplace CC, NobelProcera Implant Bar
Sponsored by
About this trial
This is an interventional treatment trial for Edentulous focused on measuring edentulous, maxilla, mandible, dental implant, bar, overdenture, Oral Health Impact Profile (OHIP), survival rate, technical complications, marginal bone level, soft tissue
Eligibility Criteria
Inclusion Criteria:
- The subject is at least 18 years of age (or age of consent) and has passed secession of growth
- The subject is not older than 70 years
- Obtained informed consent from the subject
- Edentulous mandible or maxilla providing sufficient bone whereas removable NobelProceraTM Implant Bar Overdenture on four (4) implants is regarded as an appropriate treatment solution
- The subject has an osseous architecture enough to receive four implants and a sufficient amount of bone for placing in healed or extraction sites implants with a length of at least 10mm
- The implant site is free from infection and extraction remnants
- Implants will be placed in healed or extractions sites, defined as a site with 8 weeks of healing following tooth extraction, respectively 6 months after major bone augmentation or soft tissue grafting
- Good gingival / periodontal / periapical status of opposing teeth/implants
- The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based
- The subjects as well as the implant site(s) fulfill the criteria for early loading (6 weeks until 3 months after implant placement)
- The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems
- The subject is available for the 5-year term of the investigation
- The subject is compliant with good oral hygiene
Exclusion Criteria:
- The subject is not able to give her/his informed consent of participating
- Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure
- Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or in subject history
- Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation in the head/neck area
- Alcohol or drug abuse as noted in subject records or in subject history
- Smoking of >10 cigarettes/day
- Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake
- Pathologic occlusion, e.g. severe bruxism or other destructive habits
- Lack of opposing dentition or unstable occlusion
- Ongoing infections, endodontic or periodontal problems in opposing teeth or implants
- Subject shows an unacceptable oral hygiene
- Subject has allergic or adverse reactions to the restorative material.
- Bone augmentation of more than 3mm vertical height performed less than 3 months prior to planned implant placement.
- Long-term bis-phosphonate therapy
Sites / Locations
- Guido Heydecke
- Nikolaus and Alexandra Behneke
- Eugenio Romeo
- Edoardo Stellini
- Alessandro Pozzi
- Università degli Studi di Sassari
- Marco Ferrari
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Mandible
Maxilla
Arm Description
NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)
NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)
Outcomes
Primary Outcome Measures
MBL,marginal bone level change
To evaluate and compare the clinical marginal bone level change (change MBL)in relation to defined implant reference point and different time points in the maxilla and mandible(between baseline at implant insertion and follow-up time points at 1 month, 6 month, 1 year, 2 year, 3 year and 5 year after implant insertion) of observation.
Secondary Outcome Measures
CSR implants
CSR in % of placed implants
CSR prosthetics
survival in % of placed final restorations
Gingival Status
Gingival status(Silness and Loe 1963):0 = Normal gingiva surrounding crown/control tooth,1 = Mild inflammation,2 = Moderate inflammation.3 = Severe inflammation.
Status of mucosa
0 = No keratinized mucosa.1 = Mucosa partially keratinized.2 = entire mucosa keratinized.
Bleeding tendency
(modified Sulcus Bleeding Index_mBI)(Mombelli):0 = No bleeding when a periodontal probe is passed along gingival margin adjacent to the implant.1 = Isolated bleeding spots visible. 2 = Blood forms a confluent red line on the margin 3 = Heavy or profuse bleeding.
plaque accumulation
modified Plaque Index (mPlI) (Mombelli):0 = No detectible plaque. 1 = Plaque only recognized by running a probe across the marginal surface of the implant. 2 = Plaque can be seen by the naked eye.3 = Abundance of soft matter
Pocket depths
Pocket depths measured around implants in millimeter (mm)
Full Information
NCT ID
NCT01720420
First Posted
October 22, 2012
Last Updated
July 13, 2018
Sponsor
Nobel Biocare
Collaborators
Charite University, Berlin, Germany
1. Study Identification
Unique Protocol Identification Number
NCT01720420
Brief Title
A Clinical Evaluation of NobelProcera Implant Bar Overdenture
Official Title
A Clinical Evaluation of NobelProceraTM Implant Bar Overdenture in the Mandible or Maxilla on 4 NobelReplaceTM CC Implants
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 2012 (Actual)
Primary Completion Date
April 2020 (Anticipated)
Study Completion Date
December 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nobel Biocare
Collaborators
Charite University, Berlin, Germany
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
AN OPEN 5-YEAR PROSPECTIVE, CLINICAL MULTI-CENTER STUDY on NobelProcera Implant Bar Titanium with Locator attachment and related Overdenture on 4 NobelReplace implants with conical connection (CC) in the mandible/maxilla.
Detailed Description
Study centers: 8 centers in 4 countries
Objectives of the study:
Primary Objective:
To evaluate and compare the clinical marginal bone level change (MBL) around the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible with the clinical marginal bone level change (MBL) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the maxilla for a period of 5 years.
Secondary Objectives:
To evaluate and compare the cumulative survival rate (CSR) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible with the cumulative survival rate (CSR) of the NobelReplaceTM CC implants supporting NobelProceraTM Implant Bar Overdenture (fixed-removable) in the maxilla for a period of 5 years.
To evaluate and compare the cumulative survival rate (CSR) of NobelProceraTM Implant Bar Overdenture (fixed-removable) on four (4) NobelReplace CC implants in the mandible with the cumulative survival rate (CSR) of NobelProceraTM Implant Bar Overdenture (fixed-removable) on four (4) NobelReplace CC implants in the maxilla after 5 years.
To evaluate the clinical behaviour (soft tissue behavior, clinical function, patient satisfaction, Quality of Life and prosthetic maintenance needs such as wear, chipping of denture teeth, need for exchange of attachment components) of NobelProceraTM Implant Bar Overdenture (fixed-removable) in the mandible and maxilla over 5 years of clinical function.
Study design 5-year, open, prospective, clinical multi-center study.
Number of subjects 76 (in total), 7-9 per center
Patient population Adult female or male, at least 18 (or age of consent) and not older than 70 years, suitable for treatment with implant supported bar overdentures in the edentulous mandible or maxilla.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Edentulous
Keywords
edentulous, maxilla, mandible, dental implant, bar, overdenture, Oral Health Impact Profile (OHIP), survival rate, technical complications, marginal bone level, soft tissue
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
77 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mandible
Arm Type
Experimental
Arm Description
NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)
Arm Title
Maxilla
Arm Type
Experimental
Arm Description
NobelReplace CC NobelProcera Implant Bar Titanium Overdenture (lab-made)
Intervention Type
Device
Intervention Name(s)
NobelReplace CC, NobelProcera Implant Bar
Other Intervention Name(s)
NobelReplace CC implants, NobelProcera Implant Bar Titanium, Overdenture (lab-made)
Intervention Description
Implants titanium with conical connection, individualized titanium bar
Primary Outcome Measure Information:
Title
MBL,marginal bone level change
Description
To evaluate and compare the clinical marginal bone level change (change MBL)in relation to defined implant reference point and different time points in the maxilla and mandible(between baseline at implant insertion and follow-up time points at 1 month, 6 month, 1 year, 2 year, 3 year and 5 year after implant insertion) of observation.
Time Frame
6 month, 1, 2, 3, 5 year
Secondary Outcome Measure Information:
Title
CSR implants
Description
CSR in % of placed implants
Time Frame
6 month, 1, 2, 3, 5 year
Title
CSR prosthetics
Description
survival in % of placed final restorations
Time Frame
6 month, 1, 2, 3, 5 year
Title
Gingival Status
Description
Gingival status(Silness and Loe 1963):0 = Normal gingiva surrounding crown/control tooth,1 = Mild inflammation,2 = Moderate inflammation.3 = Severe inflammation.
Time Frame
6 month, 1, 2, 3, 5 year
Title
Status of mucosa
Description
0 = No keratinized mucosa.1 = Mucosa partially keratinized.2 = entire mucosa keratinized.
Time Frame
6 month, 1, 2, 3, 5 year,
Title
Bleeding tendency
Description
(modified Sulcus Bleeding Index_mBI)(Mombelli):0 = No bleeding when a periodontal probe is passed along gingival margin adjacent to the implant.1 = Isolated bleeding spots visible. 2 = Blood forms a confluent red line on the margin 3 = Heavy or profuse bleeding.
Time Frame
6 month, 1, 2, 3, 5 year
Title
plaque accumulation
Description
modified Plaque Index (mPlI) (Mombelli):0 = No detectible plaque. 1 = Plaque only recognized by running a probe across the marginal surface of the implant. 2 = Plaque can be seen by the naked eye.3 = Abundance of soft matter
Time Frame
6 month, 1, 2, 3, 5 year
Title
Pocket depths
Description
Pocket depths measured around implants in millimeter (mm)
Time Frame
6 month, 1, 2, 3, 5 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
The subject is at least 18 years of age (or age of consent) and has passed secession of growth
The subject is not older than 70 years
Obtained informed consent from the subject
Edentulous mandible or maxilla providing sufficient bone whereas removable NobelProceraTM Implant Bar Overdenture on four (4) implants is regarded as an appropriate treatment solution
The subject has an osseous architecture enough to receive four implants and a sufficient amount of bone for placing in healed or extraction sites implants with a length of at least 10mm
The implant site is free from infection and extraction remnants
Implants will be placed in healed or extractions sites, defined as a site with 8 weeks of healing following tooth extraction, respectively 6 months after major bone augmentation or soft tissue grafting
Good gingival / periodontal / periapical status of opposing teeth/implants
The subject fulfills the prerequisite that a harmonic, stable occlusal relationship can be achieved with opposing natural teeth resp. fixed or removable opposing dentition (tooth or implant based
The subjects as well as the implant site(s) fulfill the criteria for early loading (6 weeks until 3 months after implant placement)
The subject is in such a physical and mental condition that a 5-year follow-up period can be carried out without foreseeable problems
The subject is available for the 5-year term of the investigation
The subject is compliant with good oral hygiene
Exclusion Criteria:
The subject is not able to give her/his informed consent of participating
Health conditions, which do not permit the surgical (including anesthesia) or restorative procedure
Reason to believe that the treatment might have a negative effect on the subject's overall situation (psychiatric problems), as noted in subject records or in subject history
Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous irradiation in the head/neck area
Alcohol or drug abuse as noted in subject records or in subject history
Smoking of >10 cigarettes/day
Uncontrolled diabetes, i.e. a subject with diagnosed diabetes that has a history of neglecting doctor's recommendations regarding treatment, food and alcohol intake
Pathologic occlusion, e.g. severe bruxism or other destructive habits
Lack of opposing dentition or unstable occlusion
Ongoing infections, endodontic or periodontal problems in opposing teeth or implants
Subject shows an unacceptable oral hygiene
Subject has allergic or adverse reactions to the restorative material.
Bone augmentation of more than 3mm vertical height performed less than 3 months prior to planned implant placement.
Long-term bis-phosphonate therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guido Heydecke, Prof
Organizational Affiliation
Poliklinik für Zahnärztliche Prothetik, University Hamburg
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Alessandro Pozzi, Prof
Organizational Affiliation
University of Rome, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Eugenio Romeo, Prof
Organizational Affiliation
University of Milan, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marco Ferrari, Prof
Organizational Affiliation
University of Siena, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Edoardo Stellini, Prof
Organizational Affiliation
University of Padova, Italy
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nikolaus and Alexandra Behneke, Prof., Dr.
Organizational Affiliation
University of Mainz, Germany
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Silvio Meloni, Dr.
Organizational Affiliation
Università degli Studi di Sassari
Official's Role
Principal Investigator
Facility Information:
Facility Name
Guido Heydecke
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Facility Name
Nikolaus and Alexandra Behneke
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Facility Name
Eugenio Romeo
City
Milan
ZIP/Postal Code
20143
Country
Italy
Facility Name
Edoardo Stellini
City
Padova
ZIP/Postal Code
35128
Country
Italy
Facility Name
Alessandro Pozzi
City
Rome
ZIP/Postal Code
00133
Country
Italy
Facility Name
Università degli Studi di Sassari
City
Sassari
Country
Italy
Facility Name
Marco Ferrari
City
Siena
ZIP/Postal Code
53100
Country
Italy
12. IPD Sharing Statement
Learn more about this trial
A Clinical Evaluation of NobelProcera Implant Bar Overdenture
We'll reach out to this number within 24 hrs